Noninferiority of cetuximab every-2-weeks versus standard once-weekly administration schedule for the first-line treatment of RAS wild-type metastatic colorectal cancer

Autor: Kasper, Stefan, Foch, Caroline, Messinger, Diethelm, Esser, Regina, Lamy, Francois-Xavier, Rothe, Vivien, Chen, Wenfeng, Cheng, Ann-Lii, Rouyer, Magali, Brodowicz, Thomas, Zielinski, Christoph
Zdroj: In European Journal of Cancer February 2021 144:291-301
Databáze: ScienceDirect